Success Metrics

Clinical Success Rate
82.4%

Based on 14 completed trials

Completion Rate
82%(14/17)
Active Trials
1(5%)
Results Posted
21%(3 trials)
Terminated
3(14%)

Phase Distribution

Ph phase_4
1
5%
Ph phase_1
8
38%
Ph phase_2
6
29%
Ph phase_3
5
24%

Phase Distribution

8

Early Stage

6

Mid Stage

6

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
8(40.0%)
Phase 2Efficacy & side effects
6(30.0%)
Phase 3Large-scale testing
5(25.0%)
Phase 4Post-market surveillance
1(5.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.4%

14 of 17 finished

Non-Completion Rate

17.6%

3 ended early

Currently Active

1

trials recruiting

Total Trials

21

all time

Status Distribution
Active(2)
Completed(14)
Terminated(3)
Other(2)

Detailed Status

Completed14
Terminated3
unknown2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
1
Success Rate
82.4%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (40.0%)
Phase 26 (30.0%)
Phase 35 (25.0%)
Phase 41 (5.0%)

Trials by Status

completed1467%
terminated314%
not_yet_recruiting15%
active_not_recruiting15%
unknown210%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07468448Phase 3

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)

Not Yet Recruiting
NCT05122455Phase 2

Effects of Edoxaban on Platelet Aggregation

Completed
NCT02618577Phase 3

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Terminated
NCT03047837Phase 2

A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients

Terminated
NCT03003325Phase 2

The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV

Completed
NCT05625334Phase 1

Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.

Completed
NCT03428373Phase 2

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Active Not Recruiting
NCT04937088Phase 2

Outpatient Liquid Aspirin (OLA)

Unknown
NCT04229264Phase 3

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

Unknown
NCT00137033Phase 4

Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population

Completed
NCT04001374

Platelet Sub-study of the TWILIGHT Trial

Completed
NCT02064439Phase 3

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Completed
NCT01568112Phase 3

Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate

Completed
NCT01744288Phase 1

Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets

Completed
NCT02120092Phase 2

The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man

Completed
NCT01015729Phase 1

Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

Terminated
NCT00425074Phase 1

Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.

Completed
NCT00998075Phase 1

Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately

Completed
NCT01094483Phase 1

A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

Completed
NCT00853450Phase 1

Bleeding Time Study With AZD6482, Clopidogrel and ASA

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21